FindTrial
Sign In

Real world data study on the impact of low-dose efavirenz to ainuovirine on the related quality of life of AIDS patients

Real world data study on the impact of low-dose efavirenz to ainuovirine on the related quality of life of AIDS patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078465
Enrollment
Unknown
Registered
2023-12-08
Start date
2024-01-01
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Interventions

Observers:None

Sponsors

The First People's Hospital of Linping District, Hangzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: For treated patients who have been treated with the 400 l irfeviren regimen for at least 6 months, HIV RNA<20 copies/ml; Age 18 and above, both male and female; Willing to participate in this study; Ability to complete the questionnaire survey in the assessment in terms of physical condition.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Hospital Anxiety and Depression Scale;Pittsburgh sleep quality index;EQ-5D;—

Countries

China

Contacts

Public ContactChunhui Yan

The First People's Hospital of Linping District, Hangzhou

dingdang_78@hotmail.com+86 135 8815 0951

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026